Nigel S. B. Rawson
Nigel S. B. Rawson publishes mostly in Economics and Econometrics, Toxicology and Pediatrics, Perinatology and Child Health, on topics such as Health Systems, Economic Evaluations, Quality of Life, Pharmaceutical Economics and Policy and Pharmacovigilance and Adverse Drug Reactions.
- World rank
- #965,644 of 7,710,434 ranked researchers
- Rank in Canada
- #33,095 of 183,316
- Works
- 122
- Citations
- 2.3k
- Citations per work
- 19.1
What does Nigel S. B. Rawson research?
Nigel S. B. Rawson's work is mostly in Economics, Econometrics and Finance (34%), Medicine (13%), Pharmacology, Toxicology and Pharmaceutics (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else5343.3%
- Social Sciences4234.3%
- Health Sciences1512.6%
- Medicine1512.6%
- Life Sciences129.8%
- 1Economics and Econometrics34% of their works
- 2Toxicology5% of their works
- 3Pediatrics, Perinatology and Child Health5% of their works
- 4Pharmacology5% of their works
- 5Epidemiology5% of their works
- 6Cardiology and Cardiovascular Medicine3% of their works
Research topics
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Pharmacovigilance and Adverse Drug Reactions
- Pharmaceutical industry and healthcare
- Pharmaceutical studies and practices
- Pharmaceutical Practices and Patient Outcomes
- Economic and Financial Impacts of Cancer
- Genomics and Rare Diseases
Which keywords describe Nigel S. B. Rawson's research?
The keywords of their largest research topics: Pharmaceutical Industry, Cost-effectiveness Analysis, Drug Development Costs, Generic Drugs, Quality of Life, Adverse Drug Reactions, Clinical Trials and Pharmacovigilance.
- Genetic Variants
- Inappropriate Medication Use
- Cost of Care
- Off-Label Drug Use
- Conflict of Interest
- Pharmacovigilance
- Adverse Drug Reactions
- Generic Drugs
- Cost-effectiveness Analysis
- Pharmaceutical Industry
- Drug Development Costs
- Quality of Life
- Clinical Trials
- Signal Detection
- Research Outcome
- Pediatric Pharmacokinetics
- Financial Toxicity
- Polypharmacy
- Sequence Interpretation
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Pharmaceutical Industry622 topics
- Cost-effectiveness Analysis491 topic
- Drug Development Costs491 topic
- Generic Drugs491 topic
- Quality of Life491 topic
- Adverse Drug Reactions282 topics
- Clinical Trials242 topics
- Pharmacovigilance171 topic
- Signal Detection171 topic
- Conflict of Interest131 topic
- Research Outcome131 topic
- Off-Label Drug Use111 topic
- Pediatric Pharmacokinetics111 topic
- Cost of Care81 topic
- Financial Toxicity81 topic
- Inappropriate Medication Use81 topic
- Polypharmacy81 topic
- Genetic Variants41 topic
- Sequence Interpretation41 topic
Where does Nigel S. B. Rawson work?
Nigel S. B. Rawson's main affiliation in the publication record is Fraser Institute, Canada.
How many publications and citations does Nigel S. B. Rawson have?
OpenAlex counts 122 works and 2,336 citations for Nigel S. B. Rawson, an h-index of 22, ranking #965,644 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Nigel S. B. Rawson. Posts are plain text and can be reported.